Skip to main content
. Author manuscript; available in PMC: 2010 Sep 20.
Published in final edited form as: ACS Chem Biol. 2009 Jun 19;4(6):435–440. doi: 10.1021/cb900043e

Figure 3.

Figure 3

Reporter gene assays of wild type AR and T877A AR mutant activity. Representative compounds show dose-dependent inhibition of full-length androgen receptor (a) or T877A full-length androgen receptor mutant (c) action. Compounds were also assayed against wild type AR (b) or T877A AR (d) activated with both 1 nM and 100 nM DHT to show the independence of CBI action from ligand concentration.